Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-22

FDA Approved: RIVASTIGMINE TARTRATE — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

The FDA granted supplemental approval for a generic rivastigmine tartrate product from Dr. Reddy's Laboratories Limited (ANDA 077130).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivastigmine tartrate (generic) (rivastigmine)

Snippet

SUPPL AP for RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)